VitaNova Life Sciences Corp
VNOV · OTCMCIK 1699709fmd_1YV3VSPHY37X9A1TDMKG477X70Wholesale Trade · Wholesale-Apparel, Piece Goods & NotionsTemplate: Standard
Coverage: Jan 23, 2016 to Jul 31, 2026, 39 periods
Loading
Latest quarter · Q1 FY2027
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (0)
- Net income
- (0)
VitaNova Life Sciences Corp (VNOV) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2026 | FY2025 | Change | Source |
|---|---|---|---|---|
| Revenue | $3 million | $2.7 million | +13.7% | 10-K 2026-07-29 · proof |
| Gross profit | $910,589 | $1.6 million | -42.2% | 10-K 2026-07-29 · proof |
| Operating income | $3,601 | $1.2 million | -99.7% | 10-K 2026-07-29 · proof |
| Net income | -$37,304 | $850,746 | -104.4% | 10-K 2026-07-29 · proof |
| Cash from operating activities | $814,407 | $192,774 | +322.5% | 10-K 2026-07-29 · proof |
| Total assets | $2.4 million | $2.3 million | +8.4% | 10-K 2026-07-29 · proof |
| Total liabilities | $395,781 | $347,567 | +13.9% | 10-K 2026-07-29 · proof |
| Cash and cash equivalents | $1.6 million | $782,810 | +104% | 10-K 2026-07-29 · proof |
- What was VitaNova Life Sciences Corp (VNOV)'s revenue in fiscal 2026?
- VitaNova Life Sciences Corp (VNOV) reported revenue of $3 million for fiscal 2026 (the year ended Apr 30, 2026), against $2.7 million the year before (+13.7%). Source: the 10-K filed with the SEC on Jul 29, 2026. SEC
- What was VitaNova Life Sciences Corp (VNOV)'s gross profit in fiscal 2026?
- VitaNova Life Sciences Corp (VNOV) reported gross profit of $910,589 for fiscal 2026 (the year ended Apr 30, 2026), against $1.6 million the year before (-42.2%). Source: the 10-K filed with the SEC on Jul 29, 2026. SEC
- What was VitaNova Life Sciences Corp (VNOV)'s operating income in fiscal 2026?
- VitaNova Life Sciences Corp (VNOV) reported operating income of $3,601 for fiscal 2026 (the year ended Apr 30, 2026), against $1.2 million the year before (-99.7%). Source: the 10-K filed with the SEC on Jul 29, 2026. SEC
- What was VitaNova Life Sciences Corp (VNOV)'s net income in fiscal 2026?
- VitaNova Life Sciences Corp (VNOV) reported net income of -$37,304 for fiscal 2026 (the year ended Apr 30, 2026), against $850,746 the year before (-104.4%). Source: the 10-K filed with the SEC on Jul 29, 2026. SEC
- What was VitaNova Life Sciences Corp (VNOV)'s cash from operating activities in fiscal 2026?
- VitaNova Life Sciences Corp (VNOV) reported cash from operating activities of $814,407 for fiscal 2026 (the year ended Apr 30, 2026), against $192,774 the year before (+322.5%). Source: the 10-K filed with the SEC on Jul 29, 2026. SEC
- What are VitaNova Life Sciences Corp (VNOV)'s total assets?
- As of Apr 30, 2026, VitaNova Life Sciences Corp (VNOV) reported total assets of $2.4 million, against $2.3 million a year earlier (+8.4%). Source: the 10-K filed with the SEC on Jul 29, 2026. SEC
- What are VitaNova Life Sciences Corp (VNOV)'s total liabilities?
- As of Apr 30, 2026, VitaNova Life Sciences Corp (VNOV) reported total liabilities of $395,781, against $347,567 a year earlier (+13.9%). Source: the 10-K filed with the SEC on Jul 29, 2026. SEC
- What are VitaNova Life Sciences Corp (VNOV)'s cash and cash equivalents?
- As of Apr 30, 2026, VitaNova Life Sciences Corp (VNOV) reported cash and cash equivalents of $1.6 million, against $782,810 a year earlier (+104%). Source: the 10-K filed with the SEC on Jul 29, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:VNOV&period_type=annual&limit=5"Information only, not investment advice.